Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oncology]

R Osieka1

  • 1Rheinisch-Westfälische Technische Hochschule, Medizinische Klinik IV, Aachen.

Arzneimittel-Forschung
|February 7, 1998
PubMed
Summary
This summary is machine-generated.

Cancer treatment has evolved from holistic care to science-based methods, focusing on specific drug-target interactions. Advances in molecular biology and immunotherapy offer new, targeted cancer therapies with improved outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.

Cancer letters·2009
Same author

Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.

British journal of haematology·2008
Same author

Post-partum acquired haemophilia after IVF without recurrence during a second pregnancy obtained by IVF.

Human reproduction (Oxford, England)·2007
Same author

Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.

Leukemia·2007
Same author

[Interdisciplinary recommendations concerning the therapy for hormone-refractory prostatic carcinoma].

Aktuelle Urologie·2006

Area of Science:

  • Oncology and Pharmacology
  • Molecular Biology
  • Immunology

Context:

  • The historical shift in medicine from holistic to science-based approaches has impacted cancer treatment paradigms.
  • The introduction of palliative care reflects a growing recognition of patient-centered needs.
  • Pharmacotherapy historically relied on the 'magic bullet' concept of specific drug-target interactions.

Purpose:

  • To explore the evolution of cancer treatment strategies, emphasizing specificity in drug development.
  • To highlight the role of molecular biology in understanding drug resistance and cellular fate.
  • To discuss the potential of nucleic acid hybridization and immunotherapy in advancing cancer therapy.

Summary:

  • Cancer treatment has transitioned from holistic care to science-driven methods, emphasizing specific drug-target interactions like enzyme or receptor binding.

Related Experiment Videos

  • Molecular biology has elucidated drug resistance mechanisms and the genetic control of cellular checkpoints, influencing targeted therapies.
  • Nucleic acid hybridization and immunotherapy, including vaccination, represent emerging frontiers for precise cancer intervention.

    • Impact:

    • Advances in drug screening, molecular biology, and immunotherapy have led to curative regimens for advanced cancers.
    • Understanding cellular mechanisms allows for the exploitation of subtle differences in cancer cells for targeted treatment.
    • The development of highly specific therapies promises improved efficacy and reduced toxicity in cancer care.